The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors

Recruiting now

Conditions studied: Urinary System Carcinoma

In brief

Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intratumoral Microbiome.

Key facts

Study ID

NCT06490211

Run by

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

People needed

100

Starts

2023-11-20

Expected to finish

2026-11-20

Last updated by the study team

2024-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients were treated for bladder cancer, kidney cancer, and prostate cancer in Wuhan Union Hospital from January 2024 to January 2026;
• Aged > 18 years old;
• Urinalysis, urine exfoliated cells, ultrasound, CT, and MR examinations indicated the above tumors;
• Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

You may not qualify if…

• Poor image quality;
• Incomplete clinical data or loss of follow-up;
• Presence of another primary malignant tumor other than urinary tract tumor;
• Unclear pathological diagnosis

Where it is running

• Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.